share_log

In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics

In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics

對bicycle therapeutics的5個分析師建議進行深入研究
Benzinga ·  09/06 20:01
Across the recent three months, 5 analysts have shared their insights on Bicycle Therapeutics (NASDAQ:BCYC), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月內,有5位分析師對bicycle therapeutics(納斯達克代碼:BCYC)發表了他們的見解,表達了從看好到看淡不同的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,展示了過去30天內不斷變化的情緒,並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $40.8, along with a high estimate of $55.00 and a low estimate of $28.00. A 6.21% drop is evident in the current average compared to the previous average price target of $43.50.
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $40.8, along with a high estimate of $55.00 and a low estimate of $28.00. A 6.21% drop is evident in the current average compared to the previous average price target of $43.50.
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
The standing of Bicycle Therapeutics among...
通過對近期分...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論